Second-Line Drugs Put Big Burden on Brazil’s AIDS Program

    The deputy director of Brazil’s Ministry of Health’s National Sexually Transmitted Diseases and AIDS (STD/AIDS) Program, Carlos Passarelli, said that the costs of this program have been growing.

    The increase has to do with new medicines that have patent protection, but he emphasized that the federal government has been negotiating with the manufacturers.

    According to Passarelli, the big increase in outlays on medicines began in 2001, when AIDS patients in Brazil began to be treated with what are referred to as second-line products.

    In an interview with the National Radio’s "Morning News" program, he explained that these treatments are more complex, employing new drugs for patients who do not respond well to first-line medications.

    Brazil has been producing first-line remedies since the start of the decade of the 1990’s, when domestic laboratories began manufacturing AZT. In 1995 government laboratories initiated production of anti-retroviral drugs.

    "The utilization of new medications implies greater costs, since they are protected by patents; thus, there is no competition in the production of these medications, because each one is manufactured exclusively by the company that holds the patent," the director observed.

    He informed that for the past two years the Ministry of Health, through its AIDS program, has been attempting to persuade government authorities to expand domestic anti-retroviral production capacity and create instruments to effectuate this production without violating international treaties.

    Agência Brasil

    Tags:

    • Show Comments (1)

    • Guest

      Full of contradiction !
      In one sentence you say that there is government laboratories producing the drugs and just after you say the drugs are manufactured !
      exclusively by the the company that holds the patent !!!!

      Furthermore you already obtained deep price cuts from many manufacturing companies.
      Therefore it is not thre drug price that went up…..by simple definition and deduction. No doubt that the increase comes from your bureaucracy….thus !

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    Electoral Fraud Still Rampant in Brazil

    The President of Brazil’s Federal Electoral Court (TSE), Minister Sepúlveda Pertence, declared that the ...

    Oil Agency Chief Betting on 7% Growth for Brazil in 2006

    The general director of the National Petroleum, Natural Gas, and Biofuels Agency (ANP), Haroldo ...

    Stack of dollars

    Brazilian Expats Send US$ 2.8 Billion Home

    Currently, Brazil ranks second in Latin America in terms of cash inflow from foreign ...

    Foot and Mouth Disease Is Back in Brazil

    Brazilian authorities confirmed Thursday, April 20, a new outbreak of the highly contagious foot ...

    Brazilian Indians Enter Information Era

    In March, the state department of Education wants to establish a program of digital ...

    Lula’s Popularity Up. And So Is the Market in Brazil.

    Latin American markets were collectively robust, despite lackluster trading in the U.S. Tempering enthusiasm ...

    Brazil Lula and US Bush

    Brazil’s Lula Has Best Regional Image, Bush and Chavez the Worst

    George Bush and Hugo Chavez, the presidents of the United States and Venezuela, are ...

    Navy’s Ship Becomes Showcase of Brazil’s War Industry

    The Brazilian Navy’s School Ship will take products made by Brazilian defense industries to ...